A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
D000328:Adult; D002318:Cardiovascular Diseases / Q000150:complications; D002769:Cholelithiasis / Q000139:chemically induced; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000009:adverse effects / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications / Q000401:mortality / Q000517:prevention & control*; D048909:Diabetes Complications; D004311:Double-Blind Method; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications; D014280:Triglycerides / Q000097:blood
D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate